Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Olalla Iglesias-García"'
Autor:
Maria Pérez-Araluce, Alessandro Cianciosi, Olalla Iglesias-García, Tomasz Jüngst, Carmen Sanmartín, Íñigo Navarro-Blasco, Felipe Prósper, Daniel Plano, Manuel M. Mazo
Publikováno v:
Antioxidants, Vol 13, Iss 10, p 1238 (2024)
The study addresses the challenge of temperature sensitivity in pristine gelatin hydrogels, widely used in biomedical applications due to their biocompatibility, low cost, and cell adhesion properties. Traditional gelatin hydrogels dissolve at physio
Externí odkaz:
https://doaj.org/article/5456ee4b05024801b6faed1f2ee9ce0e
Autor:
Pilar Montero-Calle, María Flandes-Iparraguirre, Bernd Kuebler, Begoña Arán, Eduardo Larequi, Ilazki Anaut, Giulia Coppiello, Xabier L. Aranguren, Anna Veiga, Maria Teresa Basurte Elorz, Manuel García de Yébenes, Juan J. Gavira, Felipe Prósper, Olalla Iglesias-García, Manuel M. Mazo Vega
Publikováno v:
Stem Cell Research, Vol 71, Iss , Pp 103189- (2023)
Transthyretin (TTR) amyloid cardiomyopathy (ATTR-CM) is a life-threatening disease caused by the abnormal production of misfolded TTR protein by liver cells, which is then released systemically. Its amyloid deposition in the heart is linked to cardia
Externí odkaz:
https://doaj.org/article/d9e76d653cf74761bd4fed055fcc36eb
Autor:
Maria Valls-Margarit, Olalla Iglesias-García, Claudia Di Guglielmo, Leonardo Sarlabous, Karine Tadevosyan, Roberto Paoli, Jordi Comelles, Dolores Blanco-Almazán, Senda Jiménez-Delgado, Oscar Castillo-Fernández, Josep Samitier, Raimon Jané, Elena Martínez, Ángel Raya
Publikováno v:
Stem Cell Reports, Vol 13, Iss 1, Pp 207-220 (2019)
Summary: In vitro surrogate models of human cardiac tissue hold great promise in disease modeling, cardiotoxicity testing, and future applications in regenerative medicine. However, the generation of engineered human cardiac constructs with tissue-li
Externí odkaz:
https://doaj.org/article/6f7edcad8c0b4e3580a22dd14384c3fe
Autor:
Javier Linares, Estibaliz Arellano-Viera, Olalla Iglesias-García, Carmen Ferreira, Elena Iglesias, Gloria Abizanda, Felipe Prósper, Xonia Carvajal-Vergara
Publikováno v:
Stem Cell Research, Vol 16, Iss 3, Pp 617-621 (2016)
Mef2c Anterior Heart Field (AHF) enhancer is activated during embryonic heart development and it is expressed in multipotent cardiovascular progenitors (CVP) giving rise to endothelial and myocardial components of the outflow tract, right ventricle a
Externí odkaz:
https://doaj.org/article/fabc5c9617194cf4a41ae134f23ed605
Autor:
Marcos Siguero-Álvarez, Alejandro Salguero-Jiménez, Joaquim Grego-Bessa, Jorge de la Barrera, Donal MacGrogan, Belén Prados, Fernando Sánchez-Sáez, Rebeca Piñeiro-Sabarís, Natalia Felipe-Medina, Carlos Torroja, Manuel José Gómez, María Sabater-Molina, Rubén Escribá, Ivonne Richaud-Patin, Olalla Iglesias-García, Mauro Sbroggio, Sergio Callejas, Declan P. O’Regan, Kathryn A. McGurk, Ana Dopazo, Giovanna Giovinazzo, Borja Ibañez, Lorenzo Monserrat, José María Pérez-Pomares, Fátima Sánchez-Cabo, Alberto M. Pendas, Angel Raya, Juan R. Gimeno-Blanes, José Luis de la Pompa
The complex genetics underlying human cardiac disease is evidenced by its heterogenous manifestation, multigenic basis, and sporadic occurrence. These features have hampered disease modeling and mechanistic understanding. Here, we show that 2 structu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76c9d5c2f3da4e9446d77a979ec3f9f2
http://hdl.handle.net/2445/193600
http://hdl.handle.net/2445/193600
Autor:
Laura Paz-Artigas, Pilar Montero-Calle, Olalla Iglesias-García, Manuel M. Mazo, Ignacio Ochoa, Jesús Ciriza
Publikováno v:
International Journal of Pharmaceutics. 632:122589
Autor:
Olalla Iglesias-García, Africa Vales, Adrián Ruiz-Villalba, Gloria González-Aseguinolaza, Gloria Abizanda, Beatriz Pelacho, Juan R. Rodriguez-Madoz, Paula García-Olloqui, Laura Pilar Aguado-Alvaro, Cristina Olagüe, Eduardo Larequi, Marianna Di Scala, Felipe Prosper
Publikováno v:
Journal of Tissue Engineering and Regenerative Medicine. 14:123-134
Adeno-associated viruses (AAV) have become one of the most promising tools for gene transfer in clinics. Among all the serotypes, AAV9 has been described as the most efficient for cardiac transduction. In order to achieve optimal therapeutic delivery
Autor:
Xabier L. Aranguren, Olalla Iglesias-García, Giulia Coppiello, E. Iglesias, Natalia Aguado, Antonio Lo Nigro, Felipe Prosper, Gloria Abizanda
Publikováno v:
Stem Cell Research, Vol 21, Iss C, Pp 47-50 (2017)
We generated a rat iPSC line called ATCi-rSD95 from transgenic Sprague-Dawley GFP fetal fibroblasts. Established ATCi-rSD95 cells present a normal karyotype, silencing of the transgenes and express pluripotency-associated markers. Additionally, ATCi-
Autor:
Claudia Di Guglielmo, Dolores Blanco-Almazan, Raimon Jane, Karine Tadevosyan, Maria Valls-Margarit, Oscar Castillo-Fernandez, Jordi Comelles, Elena Martínez, Roberto Paoli, Angel Raya, Olalla Iglesias-García, Senda Jiménez-Delgado, Leonardo Sarlabous, Josep Samitier
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Stem Cell Reports
Recercat. Dipósit de la Recerca de Catalunya
instname
Stem Cell Reports, Vol 13, Iss 1, Pp 207-220 (2019)
Universidad de Barcelona
UPCommons. Portal del coneixement obert de la UPC
Universitat Politècnica de Catalunya (UPC)
Stem Cell Reports
Recercat. Dipósit de la Recerca de Catalunya
instname
Stem Cell Reports, Vol 13, Iss 1, Pp 207-220 (2019)
Summary In vitro surrogate models of human cardiac tissue hold great promise in disease modeling, cardiotoxicity testing, and future applications in regenerative medicine. However, the generation of engineered human cardiac constructs with tissue-lik
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::225094f629a99b9133f1867c016cf8f0
http://hdl.handle.net/2445/159422
http://hdl.handle.net/2445/159422
Autor:
María J. Blanco-Prieto, Angel Raya, Laura Saludas, Elisa Garbayo, Olalla Iglesias-García, Beatriz Pelacho, Gloria Abizanda, Felipe Prosper, Manuel Mazo
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 370(3)
Cardiomyocytes derived from human induced pluripotent stem cells (hiPSC-CMs) are a promising cell source for cardiac repair after myocardial infarction (MI) because they offer several advantages such as potential to remuscularize infarcted tissue, in